B. C. Kieseier

2.3k total citations
62 papers, 1.2k citations indexed

About

B. C. Kieseier is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, B. C. Kieseier has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 21 papers in Immunology and 16 papers in Neurology. Recurrent topics in B. C. Kieseier's work include Multiple Sclerosis Research Studies (31 papers), Peripheral Neuropathies and Disorders (13 papers) and Immunotherapy and Immune Responses (12 papers). B. C. Kieseier is often cited by papers focused on Multiple Sclerosis Research Studies (31 papers), Peripheral Neuropathies and Disorders (13 papers) and Immunotherapy and Immune Responses (12 papers). B. C. Kieseier collaborates with scholars based in Germany, United States and Austria. B. C. Kieseier's co-authors include Heinz Wiendl, H.‐P. Hartung, John M. Clements, A. J. H. Gearing, Elliot M. Frohman, Paulo Fontoura, Laurent Suchet, R. Macdonell, Virginia Devonshire and Robert Hyde and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

B. C. Kieseier

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. C. Kieseier Germany 15 597 285 271 233 222 62 1.2k
Antonios Bayas Germany 19 459 0.8× 210 0.7× 224 0.8× 301 1.3× 216 1.0× 52 1.2k
Alexander Musallam United States 15 710 1.2× 117 0.4× 245 0.9× 179 0.8× 232 1.0× 21 1.0k
Siegrid Strasser‐Fuchs Austria 17 820 1.4× 146 0.5× 406 1.5× 235 1.0× 243 1.1× 32 1.5k
Jerome Graber United States 22 259 0.4× 180 0.6× 278 1.0× 155 0.7× 135 0.6× 71 1.4k
Martin Gunnarsson Sweden 18 1.4k 2.4× 436 1.5× 652 2.4× 291 1.2× 322 1.5× 47 2.1k
Mónica Marta United Kingdom 20 1.0k 1.8× 487 1.7× 368 1.4× 761 3.3× 307 1.4× 66 1.9k
Darius Matusevičius Sweden 17 445 0.7× 268 0.9× 181 0.7× 791 3.4× 245 1.1× 27 1.4k
Paul S. Giacomini Canada 19 662 1.1× 158 0.6× 321 1.2× 278 1.2× 195 0.9× 50 1.2k
Ana Silva Portugal 24 598 1.0× 242 0.8× 362 1.3× 284 1.2× 560 2.5× 110 1.9k
Katsuya Yamamoto Japan 20 232 0.4× 202 0.7× 128 0.5× 90 0.4× 358 1.6× 102 1.1k

Countries citing papers authored by B. C. Kieseier

Since Specialization
Citations

This map shows the geographic impact of B. C. Kieseier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. C. Kieseier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. C. Kieseier more than expected).

Fields of papers citing papers by B. C. Kieseier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. C. Kieseier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. C. Kieseier. The network helps show where B. C. Kieseier may publish in the future.

Co-authorship network of co-authors of B. C. Kieseier

This figure shows the co-authorship network connecting the top 25 collaborators of B. C. Kieseier. A scholar is included among the top collaborators of B. C. Kieseier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. C. Kieseier. B. C. Kieseier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rommer, Paulus, Thomas Dörner, Klaus Freivogel, et al.. (2015). Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID). Journal of Neuroimmune Pharmacology. 11(1). 1–8. 34 indexed citations
2.
Klotz, Luisa, Sven G. Meuth, B. C. Kieseier, & Heinz Wiendl. (2013). Alemtuzumab bei schubförmig-remittierender multipler Sklerose. Der Nervenarzt. 84(8). 984–994. 1 indexed citations
3.
Warnke, Clemens, Ortwin Adams, Ralf Gold, et al.. (2011). Progressive multifokale Leukenzephalopathie unter Natalizumab. Der Nervenarzt. 82(4). 475–480. 2 indexed citations
4.
Sabir, Hemmen, et al.. (2011). Unilateral Facial Flushing and Sweating After Physical Exercise: Harlequin Syndrome. Klinische Pädiatrie. 223(2). 90–91. 6 indexed citations
5.
Hartung, H.‐P., B. C. Kieseier, & Orhan Aktaş. (2010). Cladribin. Der Nervenarzt. 81(2). 194–202. 1 indexed citations
6.
Aktaş, Orhan, Jens Ingwersen, B. C. Kieseier, et al.. (2010). Orales Fingolimod bei Multipler Sklerose. Der Nervenarzt. 82(2). 215–225. 4 indexed citations
7.
Lehmann, Helmar C., et al.. (2010). Central nervous system involvement in patients with monoclonal gammopathy and polyneuropathy. European Journal of Neurology. 17(8). 1075–1081. 4 indexed citations
8.
Devonshire, Virginia, Yves Lapierre, R. Macdonell, et al.. (2010). The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis. European Journal of Neurology. 18(1). 69–77. 282 indexed citations
9.
Stangel, Martin, Hans‐Peter Hartung, Ralf Gold, & B. C. Kieseier. (2009). Bedeutung intravenöser Immunglobuline zur Behandlung immunvermittelter Polyneuropathien. Der Nervenarzt. 80(6). 678–687. 1 indexed citations
10.
Leussink, Verena I., et al.. (2009). Cladribine impedesin vitromigration of mononuclear cells: a possible implication for treating multiple sclerosis. European Journal of Neurology. 16(3). 409–412. 36 indexed citations
11.
Kleinschnitz, Christoph, Sven G. Meuth, B. C. Kieseier, & Heinz Wiendl. (2007). Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006. Endocrine Metabolic & Immune Disorders - Drug Targets. 7(1). 35–63. 31 indexed citations
12.
Wiendl, Heinz, B. C. Kieseier, Robert Weissert, et al.. (2007). Treatment of active secondary progressive multiple sclerosis with treosulfan. Journal of Neurology. 254(7). 884–889. 18 indexed citations
13.
Wiendl, Heinz, et al.. (2006). Multiple Sklerose – Revision der neuen McDonald-Diagnosekriterien. Der Nervenarzt. 77(10). 1235–1245. 6 indexed citations
14.
Wiendl, Heinz, Helmar C. Lehmann, Reinhard Hohlfeld, Hans‐Peter Hartung, & B. C. Kieseier. (2004). Multiple Sklerose: potenzielle Therapieansätze und Update laufender Studien. Der Nervenarzt. 75(6). 536–552. 1 indexed citations
15.
Stüve, Olaf, Sylvie Nessler, H.‐P. Hartung, et al.. (2004). Akute disseminierte Enzephalomyelitis. Der Nervenarzt. 76(6). 701–707. 13 indexed citations
16.
Lehmann, Helmar C., HP Hartung, & B. C. Kieseier. (2004). Jean-Martin Charcot im Spiegel der deutschen Nervenheilkunde. Der Nervenarzt. 75(2). 187–192. 5 indexed citations
17.
Rosche, Berit, B. C. Kieseier, H.‐P. Hartung, & Bernhard Hemmer. (2003). Neue Einblicke in die Immunpathogenese der Multiplen Sklerose. Der Nervenarzt. 74(8). 654–663. 1 indexed citations
18.
Köller, Hubertus, B. C. Kieseier, Sebastian Jander, & Hans‐Peter Hartung. (2003). Chronisch inflammatorische demyelinisierende Polyneuropathie. Der Nervenarzt. 74(4). 320–333.
19.
Kieseier, B. C., John M. Clements, A. J. H. Gearing, & Hans‐Peter Hartung. (1999). Matrix Metalloproteinases Exhibit Different Expression Patterns in Inflammatory Demyelinating Diseases of the Central and Peripheral Nervous System. Annals of the New York Academy of Sciences. 878(1). 567–570. 4 indexed citations
20.
Kieseier, B. C. & Hans H. Goebel. (1994). Characterization of T–cell subclasses and NK–cells in lysosomal disorders by immuno–electron microscopy. Neuropathology and Applied Neurobiology. 20(6). 604–608. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonios Bayas Breakdown of academic impact, for papers by Alexander Musallam Breakdown of academic impact, for papers by Siegrid Strasser‐Fuchs Breakdown of academic impact, for papers by Jerome Graber Breakdown of academic impact, for papers by Martin Gunnarsson Breakdown of academic impact, for papers by Mónica Marta Breakdown of academic impact, for papers by Darius Matusevičius Breakdown of academic impact, for papers by Paul S. Giacomini Breakdown of academic impact, for papers by Ana Silva Breakdown of academic impact, for papers by Katsuya Yamamoto
Rankless by CCL
2026